Abstract
Background Pilocytic astrocytomas (PAs) are central nervous system tumors with variable prognosis and poorly understood risk factors. Little evidence exists regarding the effect of age on mortality in PA. Therefore, we conducted a thorough characterization of PA in the US. Methods We queried the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018 to extract age-adjusted incidence rate (AAIR), age-adjusted mortality rate (AAMR), and survival data on PA. The age group comparisons for each measure varied depending on available SEER data. We compared trends in AAIR and AAMR by two age groups (children, 0–19 years; adults, 20 + years) and by sex. The cumulative incidence function and the Fine-Gray competing risk model were applied by 0–19, 20–39, 40–59, and 60 + years of age groups. Results This study included 5211 incident PA and 462 PA-specific deaths between 2000 and 2018. Trends in AAIRs and AAMRs were almost constant between 2000 and 2018. Average AAIRs had a sharp peak in 1–4 years of age groups, whereas AAMRs had a gradual peak in 80–84 years of age groups. Age groups, tumor location, and race/ethnicity were significantly associated with PA-specific death, whereas only age was associated with other cause of deaths. Conclusions Trends in AAIRs and AAMRs were constant regardless of age. PAs in older populations, especially over 60 years old, have higher incidence of death than those in younger populations.
Similar content being viewed by others
Abbreviations
- AAIR:
-
Age-adjusted incidence rate
- AAMR:
-
Age-adjusted mortality rate
- AAPC:
-
Average annual percentage change
- CODs:
-
Cause of deaths
- MC AAP:
-
Methylation class with anaplastic astrocytoma with piloid features
- MIR:
-
Mortality-to-incidence ratio
- PA:
-
Pilocytic astrocytoma
- SEER:
-
The Surveillance, Epidemiology, and End results
- SHR:
-
Subdistribution hazard ratio
- WHO:
-
World Health Organization
References
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231–51. https://doi.org/10.1093/neuonc/noab106.
Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22:iv1–96. https://doi.org/10.1093/neuonc/noaa200.
Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469–74. https://doi.org/10.1038/nature26000.
Hasselblatt M, Riesmeier B, Lechtape B, et al. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. Neuropathol Appl Neurobiol. 2011;37:803–6. https://doi.org/10.1111/j.1365-2990.2011.01193.x.
Reinhardt A, Stichel D, Schrimpf D, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018;136:273–91. https://doi.org/10.1007/s00401-018-1837-8.
Voronina N, Aichmüller C, Kolb T, et al. The age of adult pilocytic astrocytoma cells. Oncogene. 2021;40:2830–41. https://doi.org/10.1038/s41388-021-01738-0.
Tabash MA. Characteristics, survival and incidence rates and trends of pilocytic astrocytoma in children in the United States SEER-based analysis. J Neurol Sci. 2019;400:148–52. https://doi.org/10.1016/j.jns.2019.03.028.
Haifler M, Neheman A, Zisman A. Has stage migration in renal cancer run its course? A SEER database analysis. Clin Genitourin Cancer. 2020;18:e368–73. https://doi.org/10.1016/j.clgc.2020.01.005.
Hallowell BD, Endeshaw M, McKenna MT, Senkomago V, Razzaghi H, Saraiya M. Cancer mortality rates among US and foreign-born individuals: United States 2005–2014. Prev Med. 2019;126: 105755. https://doi.org/10.1016/j.ypmed.2019.105755.
Tomita Y, Tanaka Y, Takata N, Hibler EA, Hashizume R, Becher OJ. Fifteen-year trends and differences in mortality rates across sex, age, and race/ethnicity in patients with brainstem tumors. Neurooncol Adv. 2021;3:vdab137. https://doi.org/10.1093/noajnl/vdab137.
Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25. https://doi.org/10.1093/jnen/61.3.215 (Discussion 226-219).
Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol. 1994;47:1451–61. https://doi.org/10.1016/0895-4356(94)90089-2.
Sunkara V, Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer. 2015;121:1563–9. https://doi.org/10.1002/cncr.29228.
Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670–82. https://doi.org/10.1002/sim.3733.
Best B, Nguyen HS, Doan NB, et al. Causes of death in glioblastoma: insights from the SEER database. J Neurosurg Sci. 2019;63:121–6. https://doi.org/10.23736/s0390-5616.18.04599-x.
Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the surveillance, epidemiology, and end results program of the national cancer institute. J Neurooncol. 2012;108:187–93. https://doi.org/10.1007/s11060-012-0829-0.
Collins VP, Jones DT, Giannini C. Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129:775–88. https://doi.org/10.1007/s00401-015-1410-7.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. https://doi.org/10.1007/s00401-007-0243-4.
Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(563–577):vii. https://doi.org/10.1016/j.cger.2009.07.007.
Yang W, Porras JL, Khalafallah AM, Sun Y, Bettegowda A, Mukherjee D. Comparison of adult and pediatric pilocytic astrocytomas using competing risk analysis: a population-based study. Clin Neurol Neurosurg. 2022;212: 107084. https://doi.org/10.1016/j.clineuro.2021.107084.
Becker AP, Scapulatempo-Neto C, Carloni AC, et al. KIAA1549: BRAF gene fusion and FGFR1 hotspot mutations are prognostic factors in Pilocytic Astrocytomas. J Neuropathol Exp Neurol. 2015;74:743–54. https://doi.org/10.1097/nen.0000000000000213.
Ogiwara H, Bowman RM, Tomita T. Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery. 2012;70:40–7. https://doi.org/10.1227/NEU.0b013e31822ff0ed (Discussion 47-48).
Saunders DE, Phipps KP, Wade AM, Hayward RD. Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg. 2005;102:172–8. https://doi.org/10.3171/jns.2005.102.2.0172.
Bornhorst M, Frappaz D, Packer RJ. Pilocytic astrocytomas. Handb Clin Neurol. 2016;134:329–44. https://doi.org/10.1016/b978-0-12-802997-8.00020-7.
Yabuno S, Kawauchi S, Umakoshi M, et al. Spinal cord diffuse midline Glioma, H3K27M- mutant effectively treated with Bevacizumab: a report of two cases. NMC Case Rep J. 2021;8:505–11. https://doi.org/10.2176/nmccrj.cr.2021-0033.
Cella DF, Orav EJ, Kornblith AB, et al. Socioeconomic status and cancer survival. J Clin Oncol. 1991;9:1500–9. https://doi.org/10.1200/JCO.1991.9.8.1500.
Carstam L, Ryden I, Gulati S, et al. Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study. J Neurooncol. 2020;146:329–37. https://doi.org/10.1007/s11060-019-03378-7.
Sherwood PR, Dahman BA, Donovan HS, Mintz A, Given CW, Bradley CJ. Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol. 2011;101:67–74. https://doi.org/10.1007/s11060-010-0223-8.
Funding
This study was supported by JSPS KAKENHI Grant to Y.O. (Nos. JP21K20803 and JP22K16687). Other authors certify that they have no grants, equipment, drugs, and other support that facilitated the conduct of the work described in the article or the writing of the article itself.
Author information
Authors and Affiliations
Contributions
YO contributed to the study concept and design. Data collection was performed by YT, and statistical analysis was conducted by YT and YT. The first draft of the manuscript was written by YT and YT, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study utilized deidentified data from the SEER database that is a publicly available. This secondary analysis of deidentified data was reviewed and approved by the Okayama University ethics board.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tomita, Y., Hibler, E.A., Suruga, Y. et al. Age is a major determinant for poor prognosis in patients with pilocytic astrocytoma: a SEER population study. Clin Exp Med 23, 2301–2309 (2023). https://doi.org/10.1007/s10238-022-00882-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-022-00882-5